<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1128456</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2023.1128456</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Reduced urine volume and changed renal sphingolipid metabolism in P2ry14-deficient mice</article-title>
<alt-title alt-title-type="left-running-head">Baalmann et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2023.1128456">10.3389/fcell.2023.1128456</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Baalmann</surname>
<given-names>Fabian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brendler</surname>
<given-names>Jana</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Butthof</surname>
<given-names>Anne</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Popkova</surname>
<given-names>Yulia</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2174255/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Engel</surname>
<given-names>Kathrin M.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/777460/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schiller</surname>
<given-names>J&#xfc;rgen</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2160641/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Winter</surname>
<given-names>Karsten</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lede</surname>
<given-names>Vera</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ricken</surname>
<given-names>Albert</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sch&#xf6;neberg</surname>
<given-names>Torsten</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Schulz</surname>
<given-names>Angela</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/293214/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Rudolf Sch&#xf6;nheimer Institute of Biochemistry</institution>, <institution>Faculty of Medicine</institution>, <institution>Leipzig University</institution>, <addr-line>Leipzig</addr-line>, <country>Germany</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Institute of Anatomy</institution>, <institution>Faculty of Medicine</institution>, <institution>Leipzig University</institution>, <addr-line>Leipzig</addr-line>, <country>Germany</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Institute of Medical Physics and Biophysics</institution>, <institution>Faculty of Medicine</institution>, <institution>Leipzig University</institution>, <addr-line>Leipzig</addr-line>, <country>Germany</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/810362/overview">Jens Uwe Marquardt</ext-link>, University of L&#xfc;beck, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1175304/overview">Maria Battistone</ext-link>, Massachusetts General Hospital and Harvard Medical School, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/23005/overview">Oleh Pochynyuk</ext-link>, University of Texas Health Science Center at Houston, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Angela Schulz, <email>angela.schulz@medizin.uni-leipzig.de</email>; Torsten Sch&#xf6;neberg, <email>schoberg@medizin.uni-leipzig.de</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1128456</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>12</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>04</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Baalmann, Brendler, Butthof, Popkova, Engel, Schiller, Winter, Lede, Ricken, Sch&#xf6;neberg and Schulz.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Baalmann, Brendler, Butthof, Popkova, Engel, Schiller, Winter, Lede, Ricken, Sch&#xf6;neberg and Schulz</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>The UDP-glucose receptor P2RY14, a rhodopsin-like G protein-coupled receptor (GPCR), was previously described as receptor expressed in A-intercalated cells of the mouse kidney. Additionally, we found P2RY14 is abundantly expressed in mouse renal collecting duct principal cells of the papilla and epithelial cells lining the renal papilla. To better understand its physiological function in kidney, we took advantage of a P2ry14 reporter and gene-deficient (KO) mouse strain. Morphometric studies showed that the receptor function contributes to kidney morphology. KO mice had a broader cortex relative to the total kidney area than wild-type (WT) mice. In contrast, the area of the outer stripe of the outer medulla was larger in WT compared to KO mice. Transcriptome comparison of the papilla region of WT and KO mice revealed differences in the gene expression of extracellular matrix proteins (e.g., decorin, fibulin-1, fibulin-7) and proteins involved in sphingolipid metabolism (e.g., small subunit b of the serine palmitoyltransferase) and other related GPCRs (e.g., GPR171). Using mass spectrometry, changes in the sphingolipid composition (e.g., chain length) were detected in the renal papilla of KO mice. At the functional level, we found that KO mice had a reduced urine volume but an unchanged glomerular filtration rate under normal chow and salt diets. Our study revealed P2ry14 as a functionally important GPCR in collecting duct principal cells and cells lining the renal papilla and the possible involvement of P2ry14 in nephroprotection by regulation of decorin.</p>
</abstract>
<kwd-group>
<kwd>P2RY14</kwd>
<kwd>kidney</kwd>
<kwd>papilla</kwd>
<kwd>intercalated cells</kwd>
<kwd>aquaporin-2</kwd>
<kwd>sphingolipids</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Molecular and Cellular Pathology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>P2RY14 is one of the metabotropic P2 nucleotide receptors belonging to the class of rhodopsin-like G protein-coupled receptors (GPCRs). More than 20&#xa0;years ago, P2RY14 (former GPR105, KIAA0001) was deorphanized and described as a receptor for UDP-glucose and other sugar derivatives (<xref ref-type="bibr" rid="B13">Chambers et al., 2000</xref>). As other related members of the P2RY12-like group, P2RY14 transduces extracellular signals through the G<sub>i</sub> subclass of heterotrimeric G proteins (<xref ref-type="bibr" rid="B13">Chambers et al., 2000</xref>; <xref ref-type="bibr" rid="B57">Sch&#xf6;neberg et al., 2007</xref>; <xref ref-type="bibr" rid="B12">Carter et al., 2009</xref>). In addition to the G<sub>i</sub>-mediated inhibition of adenylyl cyclase activity, receptor-mediated ERK1/2 phosphorylation was observed (<xref ref-type="bibr" rid="B12">Carter et al., 2009</xref>).</p>
<p>Previous research on P2RY14 showed widespread expression and implication in many physiological processes and diseases. P2RY14 is expressed in many organs and tissues including placenta, spleen, thymus, lung, heart, brain, kidney, gastrointestinal tract, pancreas, and adipose tissue (<xref ref-type="bibr" rid="B13">Chambers et al., 2000</xref>; <xref ref-type="bibr" rid="B20">Freeman et al., 2001</xref>; <xref ref-type="bibr" rid="B42">Meister et al., 2014</xref>). In those tissues, P2RY14 expression is found in different immune and non-immune cells (for review see <xref ref-type="bibr" rid="B34">Lazarowski und Harden, 2015</xref>). Its physiological functions may include modulations of immune responses (<xref ref-type="bibr" rid="B61">Skelton et al., 2003</xref>; <xref ref-type="bibr" rid="B59">Scrivens und Dickenson, 2005</xref>; <xref ref-type="bibr" rid="B4">Arase et al., 2009</xref>; <xref ref-type="bibr" rid="B6">Barrett et al., 2013</xref>; <xref ref-type="bibr" rid="B22">Gendaszewska-Darmach et al., 2016</xref>; <xref ref-type="bibr" rid="B32">Karcz et al., 2021</xref>), hematopoietic stem cell localization and senescence (<xref ref-type="bibr" rid="B36">Lee et al., 2003</xref>; <xref ref-type="bibr" rid="B16">Cho et al., 2014</xref>), modulation of smooth muscle tone (<xref ref-type="bibr" rid="B7">Bassil et al., 2009</xref>; <xref ref-type="bibr" rid="B24">Haanes et al., 2014</xref>; <xref ref-type="bibr" rid="B42">Meister et al., 2014</xref>), glucose homeostasis (<xref ref-type="bibr" rid="B68">Xu et al., 2012</xref>; <xref ref-type="bibr" rid="B42">Meister et al., 2014</xref>), and bone metabolism (<xref ref-type="bibr" rid="B38">Lee et al., 2013</xref>; <xref ref-type="bibr" rid="B45">Mikolajewicz und Komarova, 2020</xref>). In addition, P2RY14 expression was also found in different cancers suggesting P2RY14 as potential biomarker for specific neoplasms (<xref ref-type="bibr" rid="B60">Shah et al., 2018</xref>; <xref ref-type="bibr" rid="B39">Li et al., 2021</xref>; <xref ref-type="bibr" rid="B48">Patritti-Cram et al., 2021</xref>).</p>
<p>Previously, P2ry14 expression was shown in kidney, specifically in intercalated cells type A, being involved in proinflammatory responses (<xref ref-type="bibr" rid="B5">Azroyan et al., 2015</xref>; <xref ref-type="bibr" rid="B15">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="B8">Battistone et al., 2020</xref>). Thus, receptor inactivation with a specific antagonist or gene knockout was found to be protective against acute kidney injury in a mouse model of ischemia reperfusion injury (<xref ref-type="bibr" rid="B8">Battistone et al., 2020</xref>). To further understand its physiological renal function, we took advantage of a P2ry14 reporter and gene-deficient mouse strain. Here, we report that P2ry14 is highly expressed in the renal papilla. Transcriptome, biochemical and functional studies with P2ry14-deficient mice revealed its function in renal morphology, renal sphingolipid metabolism and urine volume determination.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Material and methods</title>
<sec id="s2-1">
<title>Animals</title>
<p>P2ry14-deficient mice were generated at TAKEDA Cambridge Ltd. as described previously (<xref ref-type="bibr" rid="B42">Meister et al., 2014</xref>). Briefly, the coding region of the receptor was replaced by a lacZ expression cassette allowing galactosidase staining of cells endogenously expressing P2ry14 (<xref ref-type="bibr" rid="B42">Meister et al., 2014</xref>). Backcrossing for more than 20 generations into the C57BL/6J background generated the mouse line used in this study. The mice were kept under specific-pathogen-free conditions on a 12-h light/12-h dark cycle with <italic>ad libitum</italic> access to food and water. Experiments were performed with littermates from heterozygous parents and according to the accepted standards of animal care. Approval was given by the respective regional government agency of the State of Saxony, Germany (T46/12, T07/13, T21/18, TVV20/20). Mice were fed a regular chow or a salt (NaCl)-enriched diet (4% NaCl) (from Sniff Spezialit&#xe4;ten GmbH, Soest, Germany) (for composition see <xref ref-type="sec" rid="s13">Supplementary Table S1</xref>). Most experiments were performed with mice from both sexes. If no significant sex-specific differences were found in initial experiments, final data sets were generated from only one sex, which is given in the respective method section.</p>
</sec>
<sec id="s2-2">
<title>X-Gal and SPiDER-Gal staining of kidney cryosections</title>
<p>Kidneys from wildtype (WT) and knockout (KO) mice removed at postnatal day (pd) 1, pd 4, pd 14, pd 21, and from adult mice (8&#x2013;12&#xa0;weeks) were embedded in TissueTek<sup>&#xae;</sup> (Sakura, Torrance, CA, United States) and shock-frozen with liquid nitrogen. The tissue was cryosectioned. Ten &#xb5;m thick sections were fixed in ice cold methanol/acetone (1:1, v/v) for 1&#xa0;min and air-dried for 15&#xa0;min. For X-Gal staining the sections were incubated in an HEPES-buffered X-Gal staining solution (pH 7.5) at 37&#xb0;C overnight to detect &#x3b2;-galactosidase activity (<xref ref-type="bibr" rid="B43">Merkwitz et al., 2016</xref>). For confocal microscopy &#x3b2;-galactosidase activity was visualized using SPiDER-Gal (tebu-bio GmbH, Offenbach a. M., Germany) according to the manufacturer&#x2019;s instructions. Briefly, SPiDER-Gal stock solution was prepared according to the manufacturer&#x2019;s protocol. Sections were incubated with a 1:1000 dilution of the stock solution in HBSS buffer for 15&#xa0;min at 37&#xb0;C. Aquaporin-2 (Aqp2) staining of collecting duct cells was performed with a 1:100 dilution of anti-Aqp2-antibody (ab199975; Abcam, Cambridge, UK) and alexa-fluor 568 antibody (a-11036, 1:500, Thermo Fisher, Schwerte, Germany) as secondary antibody. For nucleus staining a 300&#xa0;nM 4&#x2032;,6-diamidin-2-phenylindol (DAPI) solution in PBS was used.</p>
</sec>
<sec id="s2-3">
<title>Fluorescence <italic>in situ</italic> hybridization</title>
<p>The RNAscope Multiplex Fluorescent Reagent Kit v2 (Advanced Cell Diagnostics [ACD], Berlin, Germany) was used to colocalize multiple RNAs on the same section. Isolated kidney halves with papillae were fixed with 4% formaldehyde for 24&#xa0;h and embedded in paraffin wax. Ten &#xb5;m thick sections were cut from the paraffin blocks and mounted on Superfrost<sup>&#xae;</sup> slides. For triple labeling, mixtures were prepared from 1:50 diluted commercially purchased probes from ACD for P2ry14 (REF: 450251), aquaporin-2 (REF: 452411-C3) and either Gpr116 (REF: 318021-C2) or pendrin (452491-C2). The freshly prepared mixtures were incubated on the sections for 2&#xa0;h at 40&#xb0;C in a HybEZ&#x2122; II manual assay hybridization system (ACD). Three consecutive amplification steps and labeling steps followed using single Opal fluorophores at dilutions of 1:750 (Akoya Biosciences, Marlborough, MA) according to manufacturer&#x2019;s instructions. P2ry14 C1-RNA was labeled with Opal 520 (OP-001001), aquaporin-2 C3-RNA was labeled with Opal 570 (OP-001003) and either Gpr116 or pendrin C2-RNA was labeled with Opal 690 (OP-001006). Between each RNA labeling step, sections were thoroughly washed with the wash buffer included in the kit. After labeling, DAPI nuclear counterstaining (Serva, Heidelberg, Germany) was performed and sections were embedded in Dako fluorescent embedding medium (Aligent, Frankfurt, Germany). The LSM 700 confocal laser-scanning microscope from Zeiss (Jena, Germany) was used to evaluate the obtained fluorescence signal<italic>.</italic> To assess the background or non-specific staining in conjunction with the RNAscope target probes used in this study, positive and negative probes from the manufacturer were used for kidney sections as technical controls. The negative probe was specific to bacterial D-box binding PAR bZIP transcription factor (dabP) mRNA and the positive control probes were specific to mouse RNA polymerase II subunit A mRNA (Polr2a (Opal 520; green), peptidylprolyl isomerase B mRNA (Ppib (Opal 570; red) and ubiquitin C mRNA (Ubc (Opal 690; white). Results are shown in <xref ref-type="sec" rid="s13">Supplementary Figure S1C</xref>.</p>
</sec>
<sec id="s2-4">
<title>Morphometric analysis</title>
<p>Fractionated series of ten &#xb5;m thick, formalin-fixed embedded WT and KO tissue sections were used. Mid-organ slices were stained with Alcian blue and Periodic-acid Schiff reagents. After manual determination of the different kidney regions, the sections were fully digitized at 20&#xd7; magnification using a digital slide scanner (Pannoramic Scan II, 3D HISTECH Ltd., Budapest, Hungary) and exported (CaseViewer, Version 2.3, 3D HISTECH Ldt., Budapest, Hungary) as images with a pixel size of 0.24&#xa0;&#xb5;m. The different areas and stripes of the kidney [cortex, outer stripe of the outer medulla (OSOM), inner stripe of the outer medulla (ISOM) and inner medulla/papilla (IM/P)] as well as all glomeruli were highlighted manually using GIMP (Version 2.10.2, The GIMP team, <ext-link ext-link-type="uri" xlink:href="http://www.gimp.org">http://www.gimp.org</ext-link>) (<xref ref-type="sec" rid="s13">Supplementary Figure S2</xref>). The area of these compartments was measured and the number of glomeruli was automatically counted using Mathematica (Version 11.3, Wolfram Research Inc., Champaign, IL, United States). Ratios of specific layers and total kidney area and glomeruli per area of cortex and total kidney were calculated and compared between WT and KO (n &#x3d; 18 sections from 11 mice per group, left and right kidney of mice). Sections with poor quality were excluded from further analysis (4 sections per group).</p>
</sec>
<sec id="s2-5">
<title>Quantitative expression analysis (RT-qPCR)</title>
<p>Kidneys were removed from WT and KO mice. For expression analysis, samples of cortex, medulla and papilla were prepared under a stereomicroscope. Tissue samples were immersed with TRIzol (Sigma-Aldrich, Merck, Darmstadt, Germany), homogenized with a Precellys<sup>&#xae;</sup> 24 homogenizer (Bertin Technologies SAS, Montigny-le-Bretonneux, France) and stored at &#x2212;80&#xb0;C until RNA preparation. Thawed homogenate was mixed with 300&#xa0;&#xb5;l chloroform and centrifuged for 5&#xa0;minutes at 13,000&#xa0;rpm. The aqueous phase was mixed with one volume of 70% ethanol and transferred to an RNeasy spin column (Qiagen, Hilden, Germany). After centrifugation and washing with buffers according to the manufacturer&#x2019;s instructions, RNA was eluted with RNase-free water. The amount of RNA was measured using a spectrophotometer (Nanodrop ND 1000; PEQLAB Biotechnologie GmbH, Erlangen, Germany). One microgram RNA was reverse transcribed with the Omniscript RT Kit (Qiagen) using mixed random hexamers and oligo (dT) primers. Quantitative PCR (qPCR) was performed with GoTaq<sup>&#xae;</sup> qPCR Master Mix (Promega, Walldorf, Germany) on a BioRad CFX Connect Real-Time-System (Bio-Rad Laboratories GmbH, Feldkirchen, Germany). The following protocol was used: 95&#xb0;C for 2&#xa0;min, 40 cycles of 95&#xb0;C for 15&#xa0;s, 63&#xb0;C for 30&#xa0;s and 95&#xb0;C for 10&#xa0;s. Prior to qPCR, primers were tested in a gradient PCR to determine the optimal annealing temperature. A melt curve was recorded to check for the presence of a single product. &#x394;Cq values were calculated using mouse &#x3b2;2-microglobulin as the reference gene. Primers used for amplification were designed spanning introns to exclude false Cq values due to contamination with genomic DNA (primer sequences are given in <xref ref-type="sec" rid="s13">Supplementary Table S2</xref>).</p>
</sec>
<sec id="s2-6">
<title>Metabolic cages</title>
<p>To quantify food and water intake and excretion, we used a metabolic cage system (TSE Systems, Bad Homburg, Germany). Eight mice were monitored in parallel in cages with <italic>ad libitum</italic> access to food and water for 72&#xa0;h. Urine and feces were collected after 24, 48, and 72&#xa0;h and analyzed afterwards. Food that accidentally fell into the collecting container was weighed and considered in the determination of the food intake. To detect individual changes in kidney function, mice were first monitored under chow diet. Subsequently, the diet was changed to a salt-enriched diet for 5&#xa0;days before mice were again monitored. Five independent experiments were conducted with three to five mice per genotype. Osmolality of the collected urine samples from chow diet-fed mice was determined with a vapor pressure osmometer 5600 (Kreienbaum Neoscience GmbH, Langenfeld, Germany). To determine the osmolality of mouse urine samples within the linear range of the instrument, the samples were diluted with distilled water.</p>
</sec>
<sec id="s2-7">
<title>Relative Inulin-FITC clearance</title>
<p>For comparison of the kidney&#x2019;s filtrating function between of WT and KO mice, the free filterable molecule inulin was used. The clearance of fluorescent-labeled inulin (inulin-FITC) was determined using a protocol described previously (<xref ref-type="bibr" rid="B52">Qi et al., 2004</xref>; <xref ref-type="bibr" rid="B51">Qi und Breyer, 2009</xref>). After anesthetizing mice with 100&#xa0;mg ketamine/10&#xa0;mg xylazine per kg body weight administered intraperitoneally and obtaining a baseline blood sample at the tail, mice were injected retroorbitally with dialyzed and diluted inulin-FITC (TdB Labs, Uppsala, Sweden). Blood samples were collected in hematocrit capillaries at 2, 4, 6, 8, 10, 15, and 30&#xa0;min after injection of inulin-FITC. Mice were kept under anesthesia during the procedure and finally sacrificed by cervical dislocation. Samples were centrifuged in a hematocrit centrifuge (Hettich Zentrifugen, Tuttlingen, Germany) for 2&#xa0;min to obtain plasma. Fluorescence measurement of plasma samples was performed with an Envision Multiplate Reader (Perkin Elmer, Rodgau, Germany) at 525&#xa0;nm. We used the decline of fluorescence as a surrogate for inulin-FITC clearance from blood. Fluorescence at 2&#xa0;min after injection was set as maximal fluorescence &#x3d; 100%. Fluorescence at the following time points was calculated as the percentage of maximal fluorescence. Samples with inadequately decreasing fluorescence (relative fluorescence at 30&#xa0;min not below 67% of maximal fluorescence) were excluded.</p>
</sec>
<sec id="s2-8">
<title>Blood pH and papillary cAMP measurement</title>
<p>Blood pH was determined with an ABL90 Flex instrument (Radiometer GmbH, Krefeld, Germany). Mice were anesthetized with ketamine/xylazine (see above), blood was taken retroorbitally with a 65-&#xb5;l capillary and blood parameters were measured according to manufacturer&#x2019;s instructions. Then, mice were sacrificed by cervical dislocation and kidneys were removed. The papilla was prepared and collected in cAMP lysis buffer. After homogenization of the tissue with a Precellys<sup>&#xae;</sup> 24 homogenizer, the protein content of the papilla samples was determined with the Pierce BCA Protein Assay Kit (Thermo Scientific). For cAMP concentration measurements, the AlphaScreen cAMP detection kit (Perkin Elmer) was used according to the manufacturer&#x2019;s instructions. The relation between protein content and cAMP concentration of the samples was calculated to compare the samples of WT and KO papillae.</p>
</sec>
<sec id="s2-9">
<title>RNA sequencing of kidney papillae</title>
<p>Female WT and KO mice were fed either chow or salt-enriched diet. Using the protocol described above for quantitative expression analysis total RNA was extracted from papillae of n &#x3d; 10 mice per group (WT/chow; KO/chow; WT/salt; KO/salt). RNA quantity was measured using a spectrophotometer (Nanodrop ND 1000). The quality of all samples was examined on the Agilent 2100 bioanalyzer (Agilent Technologies, Santa Clara, CA, United States) using the RNA 6000 Nano Chip. Only RNA samples with a RNA integrity number (RIN) above 8 were included.</p>
<p>Indexed cDNA libraries were generated using a TruSeq Stranded mRNA Library Prep Kit (Illumina, Eindhoven, Netherlands) according to the manufacturer&#x2019;s protocol. Constructed libraries had an average size of 250&#x2013;300 bp as evaluated on the Agilent 2100 bioanalyzer with a DNA 1000 Chip. Libraries were sequenced on an Illumina HiSeq 4000 with ten biological replicates per genotype. Raw paired-end reads with 101&#xa0;bp were generated with 10 samples per single flow cell lane (Macrogen, Seoul, South Korea).</p>
</sec>
<sec id="s2-10">
<title>Data analysis</title>
<p>The raw data underwent a quality check using FastQC to verify base calling correctness. Due to poor quality, the first three bases of forward-oriented reads had to be trimmed using Seqtk software (<ext-link ext-link-type="uri" xlink:href="https://github.com/lh3/seqtk">https://github.com/lh3/seqtk</ext-link>). The paired-end reads were mapped to a mouse reference genome (GRCm38/mm10) with TopHat (version 2.0.14) which uses BoWTie (version 1.1.2) for read alignment. Cufflinks (version 2.2.1) was used to calculate values of fragments per kilobase of transcript per million mapped reads (FPKM). Differential expression analysis was performed in R version 3.4.1 (2017-06-30, Core Team (2017). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL <ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.R-project.org/</ext-link>) using the DESeq2 software package (<xref ref-type="bibr" rid="B40">Love et al., 2014</xref>). It was conducted including all genes and after excluding genes with FPKM cut off values &#x3c; 1 in at least half of the samples. Differentially expressed genes with a <italic>p</italic>-value &#x3c; 0.05 were considered statistically significant. The sequences for this project were loaded into BioProject (ID: PRJNA923283).</p>
</sec>
</sec>
<sec id="s3">
<title>Lipid measurements in papilla samples</title>
<sec id="s3-1">
<title>Lipid extraction</title>
<p>Tissue samples were extracted using MMC (MeOH/MTBE/CHCl<sub>3</sub>) method according to (<xref ref-type="bibr" rid="B49">Pellegrino et al., 2014</xref>). Briefly, tissue samples were transferred into ball mill tubes (Precellys<sup>&#xae;</sup> ceramic-kit, CK14, Bertin GmbH, Frankfurt am Main, Germany) containing 665&#xa0;&#xb5;l methanol containing 1&#xa0;mM&#xa0;<italic>t</italic>-butylhydroxytoluene (BHT) preventing oxidation and homogenized using the tissue homogenizer Precellys<sup>&#xae;</sup> 24 (PEQLAB) for 2 &#xd7; 15&#xa0;s at 5,000&#xa0;rpm and put on ice immediately. After transfer of the homogenized samples into glass vials, ball mill tubes were washed with 665&#xa0;&#xb5;l methanol (containing 1&#xa0;mM BHT) to reach a total volume of 1.33 ml; afterwards, 2&#xa0;ml of MTBE/chloroform (1:1, v/v) were added to the samples. After incubation for 1&#xa0;h and shaking at 950&#xa0;rpm at room temperature using a thermoblock, samples were centrifuged for 10&#xa0;min at 2,000&#xa0;rpm. The upper phase was transferred to a glass vial. To maximize the extraction yields, the pellet was subjected to a second extraction step with MMC mixture (MeOH/MTBE/CHCl<sub>3</sub>, 1.33:1:1, v/v/v). The obtained organic phases were combined and supernatant was removed by evaporation under a gentle nitrogen steam. The samples were stored at &#x2212;20&#xb0;C until further experiments.</p>
</sec>
<sec id="s3-2">
<title>High-performance thin-layer chromatography electrospray ionization ion trap mass spectrometry (HPTLC ESI-IT MS)</title>
<p>HPTLC and ESI-IT MS measurements were performed according to <xref ref-type="bibr" rid="B18">Engel et al. (2017)</xref> with slight modifications. Lipid extracts were dissolved to give 10&#xa0;&#x3bc;g/&#x3bc;l solutions in chloroform and 10&#xa0;&#x3bc;l of each sample were sprayed onto an HPTLC silica gel 60 plate (Merck KGaA, Darmstadt, Germany) using a CAMAG<sup>&#xae;</sup> Linomat 5 semi-automatic sample application system (CAMAG, Berlin, Germany). Plates were developed in vertical TLC chambers with chloroform/ethanol/water/triethylamine (30:35:7:35, v/v/v/v) as the mobile phase. Lipids were visualized by dipping the entire plate in primuline (Direct Yellow 59, Sigma-Aldrich, Taufkirchen, Germany) dissolved in acetone/water (80:20, v/v, 50&#xa0;mg/l). Upon illumination with UV light (366&#xa0;nm), lipids were detected as colored spots. Sphingomyelin (SM) fractions were pencil-marked and automatically eluted by a Plate Express&#x2122; TLC plate reader (Advion, Ithaca, NY, United States) with methanol as the solvent and subsequently directly infused into the ESI mass spectrometer.</p>
<p>ESI-IT MS was performed on an Amazon SL mass spectrometer (Bruker Daltonics GmbH, Bremen, Germany). The following conditions were used: spray voltage 4.5&#xa0;kV, end plate offset 500&#xa0;V, nebulizer gas 7.3 psi, drying gas (N<sub>2</sub>) 3&#xa0;l/min, capillary temperature 180&#xb0;C, flow rate 3&#xa0;&#x3bc;l/min, sheath gas (He) flow rate 25 a.u. The spectra were recorded in the positive ion mode with enhanced resolution. For data acquisition and subsequent analysis, the Bruker Trap Control and Data Analysis version 4.1 software (Bruker Daltonics GmbH) were used, respectively.</p>
</sec>
<sec id="s3-3">
<title>Statistics</title>
<p>Statistical analyses were performed in GraphPad Prism (Version 6.05 for Windows, GraphPad Software, La Jolla, CA, United States). After testing for normality using the Shapiro-Wilk test samples were compared using t-test. For non-parametric statistical analyses the Mann-Whitney-U-test was used instead.</p>
</sec>
</sec>
<sec sec-type="results" id="s4">
<title>Results</title>
<sec id="s4-1">
<title>P2ry14 is mainly expressed in principal cells of the mouse renal papilla</title>
<p>To study the cellular expression of P2ry14 in the mouse kidney, we took advantage of the lacZ expression cassette replacing the P2ry14 coding exon and generating a knockout allele. As previously investigated, bacterial &#xdf;-galactosidase expression and, hence, intensity of X-Gal staining is regulated by the P2ry14 promoter and directly reflects the endogenous expression of P2ry14 in WT mouse kidneys (<xref ref-type="bibr" rid="B42">Meister et al., 2014</xref>). Most abundant X-Gal staining was observed in the kidney papilla (<xref ref-type="fig" rid="F1">Figure 1A</xref>). The staining intensity increased towards the tip of the papilla. Additional staining was detected in the outer medulla. However, only single cells dispersed in this layer showed &#xdf;-galactosidase activity (<xref ref-type="fig" rid="F1">Figure 1A</xref>). This suggested that the papilla also expresses P2ry14 within the mouse kidney in significant amounts. To validate the results of local X-Gal staining, we quantified expression of P2ry14 and the KO construct using RT-qPCR. The gene expression was analyzed in cortex, medulla and papilla from the same kidney samples of both female and male mice. To rule out expression changes due to the insertion of the lacZ reporter cassette in knockout animals, we used primers annealing to 5&#x2032;-UTR exons, which are not altered by the knockout/knockin procedure. This allowed comparing transcript levels irrespective of the genotype. The papilla showed significantly higher expression of P2ry14 compared to cortex and medulla in both sexes (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Importantly, the gene expression levels in renal medulla and papilla were not different between KO and WT mice. In general, we detected higher expression levels of P2ry14 in females tissues (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Renal P2ry14 expression is found in medulla and in the papilla. <bold>(A)</bold> Frozen sections of adult WT and KO kidneys were stained with X-Gal and counterstained with nuclear-fast red-aluminum salt. Representative regional sections of papilla and medulla are shown. &#xdf;-galactosidase-positive cells were found at the tip of the KO renal papilla and the remaining medulla. No X-Gal staining was observed in WT controls. <bold>(B)</bold> Quantitative PCR reactions were performed with cDNA generated from RNA of cortex, medulla and papilla tissue, collected from males and females of WT and P2ry14-deficient mice. &#xdf;2-microglobulin was used as housekeeping gene and gene expression is shown as &#x394;Cq values. Expression of P2ry14 is markedly higher (lower &#x394;Cq values) in the renal papilla compared to medulla and cortex. No significant difference in expression is found between WT and KO animals but a higher P2ry14 expression could be detected in females compared to males. Note, we used primers annealing to 5&#x2032;-UTR which is not altered by the knockout/knockin procedure (see <italic>Materials and Methods</italic>). WT males: n &#x3d; 8; KO males: n &#x3d; 8; WT females n &#x3d; 7, KO females: n &#x3d; 7. Data are given as mean &#xb1; SD and <italic>p</italic> values were calculated with Mann-Whitney-U-test.</p>
</caption>
<graphic xlink:href="fcell-11-1128456-g001.tif"/>
</fig>
<p>The development of the mouse kidney is not completed at birth (<xref ref-type="bibr" rid="B41">McMahon, 2016</xref>). Therefore, we examined P2ry14 expression during postnatal development using X-Gal staining of kidney sections. Thus, sections of WT (control) and KO mice at pd 1, 4, 14, and 21 were stained (<xref ref-type="fig" rid="F2">Figure 2</xref>). Only a few cells were X-Gal-positive in pd 1 sections of KO animals. However, the number of X-Gal-positive cells increased in the renal papilla within the following days and weeks after birth.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Expression of P2ry14 during postnatal kidney development. Frozen sections of postnatal renal papillae were stained with X-Gal to illustrate &#xdf;-galactosidase expression during kidney development between pd 1 and pd 21. Only a few cells express the reporter gene in pd 1 KO animals. During kidney maturation, the &#xdf;-galactosidase expression is significantly increased in the sections of KO animals. WT sections are shown for comparison (WT pups n &#x003D; 2&#x2013;3; KO pups n &#x003D; 3&#x2013;5; at particular times). P: papilla.</p>
</caption>
<graphic xlink:href="fcell-11-1128456-g002.tif"/>
</fig>
<p>Next, we determined the P2ry14-expressing cell type within the papilla. Thus, we used the fluorescent dye SPiDER-Gal, a &#xdf;-galactosidase substrate being trapped within the cell after enzymatic hydrolysis. As expected, SPiDER-Gal staining showed &#x3b2;-galactosidase expression similar to X-Gal staining in the papilla region (<xref ref-type="fig" rid="F3">Figure 3A</xref>). Counterstaining with an anti-Aqp2 antibody assigned the SPiDER-Gal signal to collecting duct principal cells (<xref ref-type="fig" rid="F3">Figure 3B</xref>). As shown in <xref ref-type="fig" rid="F3">Figure 3C</xref>, in the papilla, in addition to SPiDER-Gal/Aqp2-positive collecting duct principal cells, a fraction of SPiDER-Gal-positive cells corresponded to Aqp2-negative epithelial cells in the terminal parts of the collecting ducts and in the epithelial lining of the renal papilla.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Expression of P2ry14 and colocalization with aquaporin 2 in renal papillae. Frozen sections with renal papillae of WT (control) and KO animals were incubated with the fluorescent &#xdf;-galactosidase substrate SPiDER-Gal (tebu-bio GmbH) (green fluorescence) <bold>(A&#x2013;C)</bold>. Renal collecting duct principal cells were identified using an anti-aquaporin-2 (Aqp2) antibody (ab 199975; abcam) (red) <bold>(B,C)</bold>. As found with X-Gal, collecting duct cells in the papillar region expressed P2ry14. At the tip of the renal papilla <bold>(C)</bold> a substantial number of Aqp2-negative cells in the terminal parts of the collecting ducts and in the epithelium lining the tip of the renal papilla expressed P2ry14 in addition.</p>
</caption>
<graphic xlink:href="fcell-11-1128456-g003.tif"/>
</fig>
<p>Because commercially available antibodies against P2ry14 failed to convincingly identify P2ry14 positive cells in WT compared to KO mice, we focused on <italic>in-situ</italic> hybridization to further characterize the cell populations expressing P2ry14. Azroyan et al. showed P2ry14 expression only in type A intercalated cells (A-ICs) of the medulla using a mouse model expressing EGFP under control of the V-ATPase promoter (<xref ref-type="bibr" rid="B5">Azroyan et al., 2015</xref>). Our data from X-Gal and SPiDER-Gal experiments (see above) in KO animals indicate that P2ry14 expression is not limited to intercalated cells. To rule out the possibility that the co-expression of P2ry14 with Aqp2 in principal cells of the papilla is due to ectopic expression of the lacZ reporter gene, we used cell type-specific hybridization probes for cell discrimination in papillae of WT animals. As shown in <xref ref-type="fig" rid="F4">Figure 4</xref>, principal cells were labeled with the Aqp2 probe, A-ICs with a probe showing adhesion receptor Gpr116 mRNA expression (<xref ref-type="bibr" rid="B70">Zaidman et al., 2020</xref>) and a pendrin probe for type B intercalated cells (B-ICs). Physiological expression of P2ry14 in the mouse kidney was restricted to the outer medulla (<xref ref-type="fig" rid="F4">Figure 4A</xref>) and the renal papilla (<xref ref-type="fig" rid="F4">Figure 4B</xref>). In the cortex, only single cells with a low but P2ry14-specific signal within collecting duct segments were detected when WT and KO tissues were compared (<xref ref-type="sec" rid="s13">Supplementary Figure S2A</xref>). The probes for Gpr116 (type A-ICs) and pendrin (type B-ICs) showed localization of IC cells between Aqp2-positive principal cells of collecting ducts (<xref ref-type="fig" rid="F4">Figure 4A</xref>; <xref ref-type="sec" rid="s13">Supplementary Figure S2A</xref>). In the outer medulla a P2ry14-positive staining of Gpr116-positive IC cells was found indicating and confirming expression of P2ry14 in type A-ICs (<xref ref-type="fig" rid="F4">Figure 4A</xref>) (<xref ref-type="bibr" rid="B5">Azroyan et al., 2015</xref>; <xref ref-type="bibr" rid="B15">Chen et al., 2017</xref>). In comparison, the P2ry14-staining of Gpr116-positive IC cells was lost in KO tissue (<xref ref-type="sec" rid="s13">Supplementary Figure S2B</xref>). As described in the literature, type B-ICs are only present in the renal cortex but not in the medulla (for review see <xref ref-type="bibr" rid="B2">Al-Awqati et al., 2011</xref>). Consistently, pendrin expression was only detectable in the cortex (<xref ref-type="sec" rid="s13">Supplementary Figure S2A</xref>). In the tip of the renal papilla, considerable P2ry14 staining was detectable in the collecting duct system in WT tissue. Most P2ry14-positive cells colocalized with Aqp2 showing expression of P2ry14 in collecting duct principal cells of the renal papilla. P2ry14-positive cells were also seen in the papilla tip-lining epithelia (<xref ref-type="fig" rid="F4">Figure 4B</xref>). Interestingly, the presumably unspecific red background seen in the cortex and medulla of WT and KO kidney was absent in the papilla. Despite the lack of IC cells in the papilla tip, the Gpr116 probe showed an expression of Gpr116 (<xref ref-type="fig" rid="F4">Figure 4B</xref>; <xref ref-type="sec" rid="s13">Supplementary Figure S2B</xref>). In contrast to the expression in type A-ICs in the outer medulla, the papillary expression of Gpr116 was seen in the interstitial tissue surrounding the collecting ducts.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Analysis of P2ry14 expressing cells in the kidney by <italic>in-situ</italic> hybridization. For verification of P2ry14 expression in type A-ICs in the outer medulla and in principal cells of the renal papilla of mice <italic>in-situ</italic> hybridization with WT tissue was performed. To differentiate type A- and type B-ICs from collecting duct principal cells, tissues were co-stained with probes for Gpr116 (A-ICs), pendrin (B-ICs) and Aqp2 (collecting duct principal cells). In the renal outer medulla <bold>(A)</bold>, P2ry14-positive signals (red) were found exclusively in Gpr116-positive cells (white, left side) indicating expression in type A-ICs. No pendrin-positive cells were noted (missing white signal, right side) supporting the finding of type B-ICs only in cortex of mouse kidneys. In WT renal papillae <bold>(B)</bold> a strong P2ry14-positive signal was detected. Here, P2ry14 colocalizes with Aqp2-positive collecting duct principal cells and epithelial cells lining the tip of the renal papilla.</p>
</caption>
<graphic xlink:href="fcell-11-1128456-g004.tif"/>
</fig>
<p>Our <italic>in-situ</italic> hybridization results confirmed the X-Gal and SPiDER-Gal experiments with KO animals showing that &#xdf;-galactosidase expression in KO kidneys perfectly reflects P2ry14 expression in WT kidneys and underscores that P2ry14 expression is not restricted to intercalated cells but is particularly high in principal cells of the renal papilla and in cells lining the papilla.</p>
</sec>
<sec id="s4-2">
<title>Loss of P2ry14 alters the microscopic structure of the mouse kidney</title>
<p>The P2ry14 expression increases during maturation of the kidney after birth (<xref ref-type="fig" rid="F2">Figure 2</xref>). To determine whether P2ry14 influences the development and structure of the kidney, we compared the histological structure of kidneys from WT and KO mice. Alcian blue- and PAS-stained sections displaying the entire kidney were prepared from kidneys of both sides. After manual delimitation of the different areas, the number of glomeruli and the size of different subareas (<xref ref-type="sec" rid="s13">Supplementary Figure S2</xref>) were determined. The comparison of total and of distinct kidney areas revealed differences between WT and KO (<xref ref-type="sec" rid="s13">Supplementary Table S3</xref>). The total kidney area was significantly larger in KO animals compared to WT animals (<xref ref-type="sec" rid="s13">Supplementary Table S3</xref>). The ISOM and the IM/P showed no significant difference between WT and KO kidneys (<xref ref-type="sec" rid="s13">Supplementary Table S3</xref>). However, significant differences were found for the cortex, the OSOM and the glomeruli number when referred to the cortex area. KO mice had a broader cortex relative to the total kidney area than WT mice. In contrast, the area of the OSOM was smaller in KO compared to WT mice. The number of glomeruli per cortex area was significantly lower in KO mice but the absolute number of glomeruli per kidney was not different (<xref ref-type="sec" rid="s13">Supplementary Table S3</xref>). Our results indicate, that loss of P2ry14 in KO mice influences the kidney size and architecture resulting in broader cortex <italic>versus</italic> OSOM areas whereas the total number of glomeruli was not different.</p>
</sec>
<sec id="s4-3">
<title>P2ry14-deficiency causes major transcriptomic changes in renal papillae</title>
<p>Previous results of Azroyan (<xref ref-type="bibr" rid="B5">Azroyan et al., 2015</xref>), our group (<xref ref-type="bibr" rid="B42">Meister et al., 2014</xref>) and of this study (see above) indicated that P2ry14 may play a role in kidney development and function. To expose the underlying mechanisms, we investigated transcriptomic changes in papillae of WT and KO female mice under regular chow and under a NaCl-enriched diet (salt challenging conditions). Thus, mice were split into four groups (WT/chow; KO/chow; WT/salt; KO/salt). As expected, genes that are characteristic for kidney papillae were expressed in all samples (<xref ref-type="sec" rid="s13">Supplementary Table S4</xref>). Aqp2 and the subunit B1 of the proton transporting V-ATPase ATP6V1 (<xref ref-type="bibr" rid="B37">Lee et al., 2015</xref>; <xref ref-type="bibr" rid="B17">Clark et al., 2019</xref>; <xref ref-type="bibr" rid="B70">Zaidman et al., 2020</xref>) are among these genes. Furthermore, the data from KO mice showed a strong decrease in reads mapped to the P2ry14 gene confirming the successful knockout. Because only the coding exon of P2ry14 is deleted and the non-coding exons are still present in our mouse strain, reads of the 5&#x2032;UTR still map to the P2ry14 gene allowing expression analysis even in KO samples (<xref ref-type="sec" rid="s13">Supplementary Table S4</xref> for FPKM values, <xref ref-type="sec" rid="s13">Supplementary Tables S5, S6</xref> for differential expression analysis).</p>
<p>The total number of differentially expressed genes between the different groups is shown in <xref ref-type="sec" rid="s13">Supplementary Figure S3A</xref>. Interestingly, the number of differentially expressed genes were more dependent on the diet (chow vs. salt-enriched diet) than of the genotype as found with the principal component analysis (<xref ref-type="sec" rid="s13">Supplementary Figure S3B</xref>). This is in line with a previous study showing the eminent influence of the diet on gene expression rather than of the genotype (<xref ref-type="bibr" rid="B35">Lede et al., 2017</xref>). Among those genes which are significantly regulated by salt in both WT and KO are GPCRs (Avpr2, Fzd1), B cell leukemia/lymphoma 6 (Bcl6), ATPases (Atp6v0a4, Atp6v0d2, Atp6v1g3), and arginase type II (Arg2), all known to show significant expression changes upon high-salt diet (<xref ref-type="bibr" rid="B64">Swanson et al., 2019</xref>). Gene ontology (GO) analysis of significantly expressed genes between WT and KO and the diets revealed only unspecific categories if significance of the false discovery rate is considered (<xref ref-type="sec" rid="s13">Supplementary Table S7</xref>). However, if only significance of <italic>p</italic> values is considered, some categories related to specific kidney functions are found in both chow and salt diets as well as WT and KO including mitochondrial functions and lipid metabolism.</p>
<p>To identify genes significantly regulated by P2ry14, we extracted genes that were differentially expressed between WT and KO mice under chow as well as salt-enriched diet. This resulted in a total of 25 significantly changed transcripts. Of these, 19 genes were regulated concordantly. Examples include transcripts for proteins that are components of the extracellular matrix (e.g., decorin, fibulin-1, fibulin-7) and proteins involved in SM metabolism (e.g., serine palmitoyltransferase, small subunit b) (see <xref ref-type="sec" rid="s13">Supplementary Table S8</xref>). Decorin is a proteoglycan involved in interactions with collagens and forms complexes with TGF-&#xdf; resulting in changes of TGF-&#xdf; signaling (<xref ref-type="bibr" rid="B69">Yamaguchi et al., 1990</xref>; <xref ref-type="bibr" rid="B73">Hildebrand et al., 1994</xref>). Fibulins are secreted glycoproteins with Ca<sup>2&#x2b;</sup>-binding motifs interacting with different proteins and proteoglycans in the extracellular environment (<xref ref-type="bibr" rid="B74">Argraves et al., 1990</xref>). The serine palmitoyltransferase (SPT) is the rate-limiting enzyme in the <italic>de-novo</italic> biosynthesis of SM. It is a trimeric enzyme composed of two large and one small subunits. The large subunits are either SPTLC1 and SPTLC2 or SPTLC1 and SPTLC3. Full activity is conferred by an additional small subunit: SPTssa or SPTssb. Isoenzymes with a specific combination of subunits have preferences for different acyl-CoA species (<xref ref-type="bibr" rid="B25">Han et al., 2009</xref>). Strong downregulation of one of these small subunits points to possible changes in pathways involved in the biosynthesis of SM. Almost all subunits of the enzyme were expressed abundantly in the renal papilla except for the large subunit Sptlc3 (<xref ref-type="sec" rid="s13">Supplementary Table S5</xref>). Our transcriptome approach revealed a significant downregulation of Sptssb in KO mice under both diets. The other subunits were not differentially expressed between WT and KO papillae (<xref ref-type="sec" rid="s13">Supplementary Tables S5, S6</xref>).</p>
<p>The differential expression of Sptssb prompted us to screen for additional changes in the expression of genes involved in SM metabolism and signaling. In chow-fed mice, downregulation of sphingosine-1-phosphate receptor 3, alkaline ceramidase 2 and UDP-glucose ceramide glucosyltransferase was observed in P2ry14 KO mice. Papilla samples of mice fed with a salt-enriched diet showed upregulation of sphingosine-1-phosphate phosphatase 2 (Sgpp2) and ceramide-1-phosphate transfer protein (Cptp) as well as downregulation of acid lysosomal sphingomyelin phosphodiesterase 1 (Smpd1) in P2ry14-deficient mice. Results are illustrated in <xref ref-type="fig" rid="F5">Figure 5</xref> (for statistical data see <xref ref-type="sec" rid="s13">Supplementary Table S6</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Changes in the sphingomyelin pathway in P2ry14-deficient mice. Several components involved in sphingomyelin pathway are shown. P2ry14 deficiency (KO) led to increased (green) and decreased (red) transcription of different genes compared to WT mice. Transcription changes between KO and WT under chow <bold>(A)</bold> and salt-enriched diet <bold>(B)</bold> are illustrated. For detailed statistical data of the RNA sequencing experiments see <xref ref-type="sec" rid="s13">Supplementary Tables S5, S6</xref>. (aCer2: alkaline ceramidase 2; Cerk: ceramide kinase; Cers: ceramide synthase; Cptp: ceramide-1-phosphate-transfer protein; Dhcd: dihydroceramide desaturase; ER: endoplasmic reticulum; Kdsr: 3-ketodihydrosphingosine reductase; S1P: sphingosine-1-phosphate; S1pr3: sphingosine-1-phosphate receptor 3; Sgpp2: sphingosine-1-phosphate phosphatase 2; SMase: sphingomyelinase; Sms: sphingomyelin synthase; Sphk1,2: sphingosine kinase 1 and 2; Spt: serine palmitoyltransferase; ssb: small subunit b; Ugcg: UDP-glucose ceramide glucosyltransferase).</p>
</caption>
<graphic xlink:href="fcell-11-1128456-g005.tif"/>
</fig>
<p>To investigate the distribution of Spt subunits in different regions of the mouse kidney, we performed quantitative expression analysis using RT-qPCR on samples of three WT mice. The three large subunits of Spt were expressed in renal cortex, medulla and papilla but the expression levels differed substantially. Sptlc2 seems to be the dominant large subunit of Spt in the mouse kidney (&#x394;Cq values to &#xdf;2-microglobulin: Sptlc1: cortex &#x3d; 6.29 &#xb1; 0.25; medulla &#x3d; 5.78 &#xb1; 0.43; papilla &#x3d; 4.24 &#xb1; 0.88; Sptlc2: cortex &#x3d; 1.86 &#xb1; 0.45; medulla &#x3d; 2.24 &#xb1; 0.71; papilla &#x3d; 1.20 &#xb1; 0.26; Sptlc3: cortex &#x3d; 7.69 &#xb1; 0.31; medulla &#x3d; 9.01 &#xb1; 1.47; papilla &#x3d; 8.31 &#xb1; 0.24). The small regulatory subunits of Spt, Sptssa and Sptssb, were also expressed in all renal areas but the expression of Sptssb differed markedly between the different kidney regions. We found a considerable increase in expression of Sptssb from cortex to papilla. The expression of both regulatory subunits a and b in the kidney papilla was similar (&#x394;Cq values to &#xdf;2 microglobulin: Sptssb: cortex &#x3d; 9.53 &#xb1; 0.67; medulla &#x3d; 6.96 &#xb1; 1.62; papilla &#x3d; 0.64 &#xb1; 0.73; Sptssa: cortex &#x3d; 2.70 &#xb1; 0.48; medulla &#x3d; 2.57 &#xb1; 0.69; papilla &#x3d; 0.74 &#xb1; 0.51).</p>
</sec>
<sec id="s4-4">
<title>Renal sphingolipid metabolism in P2ry14-deficient mice</title>
<p>To study the biological significance of the downregulation of Sptssb in KO papillae, we collected papillae from WT and KO mice and performed SM analysis using HPTLC and ESI-IT MS measurements. The total amount of sphingomyelins (SM) was not significantly different between WT and KO mice (<xref ref-type="sec" rid="s13">Supplementary Figure S4</xref>). Next, we analyzed the fatty acid chain composition of SM and found a number of significant differences (<xref ref-type="fig" rid="F6">Figure 6</xref>). For example, we found a significant reduction of the SM(d18:1/16:0) species in KO mouse papillae whereas SM(d18:1/24:X) species were increased (<xref ref-type="fig" rid="F6">Figure 6</xref>). P2ry14 deficiency resulted in a shift to SM with greater chain lengths compared to WT samples.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Analysis of sphingomyelin (SM) species in WT and KO papillae. WT and KO papillae were prepared, lipids were extracted by the MTBE method and HPTLC with subsequent ESI-IT MS measurements were performed (see Materials and Methods). Comparison of the relative amounts of different SM species (ratio of total SM; total SM &#x3d; 1) of WT and KO papillae are shown. The numbers given in parentheses [e.g., SM(d18:1/16:0)] refer to the length of the two carbon chains and the number of double bounds. Statistical analysis was performed with GraphPad Prism 6 using the Mann-Whitney-U-test.</p>
</caption>
<graphic xlink:href="fcell-11-1128456-g006.tif"/>
</fig>
</sec>
<sec id="s4-5">
<title>Excretion of urine is decreased in knockout mice</title>
<p>To examine whether P2ry14 deletion results in changes in kidney function, we kept WT and KO mice in metabolic cages. Mice initially received regular chow diet (first phase) followed by challenging kidney function with a salt-enriched diet (second phase) after an adaptation period in between. Food and water consumption as well as excretion were recorded. After excluding invalid samples, a total of 16 mice per group were eligible for further analysis. The food intake was measured constantly over 72&#xa0;h and did not differ significantly under both chow and salt diet between WT and KO mice (chow: WT &#x3d; 4.63 &#xb1; 4.03 g; KO &#x3d; 4.69 &#xb1; 4.27 g; <italic>p</italic> &#x3d; 0.945 salt: WT &#x3d; 3.6 &#xb1; 0.42 g; KO &#x3d; 3.32 &#xb1; 0.92 g; <italic>p</italic> &#x3d; 0.29). Similar results were seen with respect to water consumption. Although we found a tendency to lower water consumption in KO mice (chow: WT &#x3d; 3.25 &#xb1; 1.14 ml; KO &#x3d; 2.52 &#xb1; 1.33 ml; <italic>p</italic> &#x3d; 0.28; salt: WT &#x3d; 7.48 &#xb1; 1.93 ml; KO &#x3d; 7.07 &#xb1; 6.06 ml; <italic>p</italic> &#x3d; 0.09).</p>
<p>Feces and urine were collected and measured every 24&#xa0;h. No difference in the amount of feces was found between WT and KO mice (chow: WT &#x3d; 1.226 &#xb1; 0.397 g; KO &#x3d; 1.363 &#xb1; 0.476 g; <italic>p</italic> &#x3d; 0.220; salt: WT &#x3d; 0.492 &#xb1; 0.086 g; KO &#x3d; 0.453 &#xb1; 0.140 g; <italic>p</italic> &#x3d; 0.355). However, we found the daily urine volume to be significantly lower in KO compared to WT mice. This was seen under chow as well as under salt-enriched diet (<xref ref-type="fig" rid="F7">Figure 7</xref>). To see if this difference is due to a reduced kidney function, we measured and analyzed the decrease of FITC-inulin fluorescence in serum samples of four WT and seven KO mice (<xref ref-type="bibr" rid="B52">Qi et al., 2004</xref>; <xref ref-type="bibr" rid="B51">Qi und Breyer, 2009</xref>). We found no significant difference in fluorescence at any time point indicating no significant difference in kidney&#x2019;s filtrating function between WT and KO mice (<xref ref-type="sec" rid="s13">Supplementary Table S9</xref>). Furthermore, the reduced urine volume may result from different cAMP levels in the collecting ducts because cAMP is the main second messenger promoting Aqp2 plasma membrane insertion. However, the cAMP content in the papillae of WT and KO was not different between both genotypes (ratio cAMP content/protein concentration; chow: WT &#x3d; 3.77 &#xb1; 2.80, n &#x3d; 13; KO &#x3d; 3.99 &#xb1; 1.97, n &#x3d; 11; <italic>p</italic> &#x3d; 0.76). This is in line with unchanged mRNA expressions of the vasopressin receptor type 2 (Avpr2), Gs protein (Gnas), adenylyl cyclases (Adcy4-7, 9), PKA (Prkaca, Prkacb), phosphodiesterases 3/4 (Pde3a, Pde3b, Pde4a), and Aqp2 signaling pathway between WT and KO (<xref ref-type="sec" rid="s13">Supplementary Table S6</xref>). Furthermore, the urine osmolalities determined every 24&#xa0;h over 3 days from WT and KO mice were not significantly different between the genotypes (chow: WT &#x3d; 3612 &#xb1; 421 mosmol/kg, n &#x3d; 13; KO &#x3d; 3760 &#xb1; 820 mosmol/kg, n &#x3d; 11; <italic>p</italic> &#x3d; 0.88). This supports the above findings that a decreased reabsorption of water is not the cause of the reduced urine volumes in KO mice. Finally, we analyzed blood pH of WT and KO mice because P2ry14 is expressed in outer medullary type A-ICs, which are involved in acid-base regulation. No significant difference was detected between WT and KO mice, indicating that loss of P2ry14 expression in A-ICs has no prominent impact on blood pH levels (WT &#x3d; 7.23 &#xb1; 0.07, n &#x3d; 17; KO &#x3d; 7.21 &#xb1; 0.10, n &#x3d; 14; <italic>p</italic> &#x3d; 0.85).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>The daily urine volume is reduced in KO mice. WT and KO mice in metabolic cages received regular chow diet (first phase) followed by a salt-enriched diet (second phase) after an adaptation period in between. Daily urine excretion was recorded. The Mann-Whitney-U-test was used, n &#x3d; 16 per group.</p>
</caption>
<graphic xlink:href="fcell-11-1128456-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s5">
<title>Discussion</title>
<p>We used a knockout/lacZ-knockin mouse model to investigate the expression and function of P2ry14 in the kidney. We found that P2ry14 is highly expressed in the renal papilla (<xref ref-type="fig" rid="F1">Figure 1</xref>) with increasing intensity towards the tip of the papilla. At birth, the expression of P2ry14 is rather low, but increases rapidly during postnatal development (<xref ref-type="fig" rid="F2">Figure 2</xref>). Little is known about renal P2ry14 function. Azroyan and coworkers (2015) proposed a proinflammatory function of the receptor in the kidney. Consequently, genetical loss or pharmacological inhibition of P2ry14 turned out to be protective against acute kidney injury in a mouse model of ischemia reperfusion injury (<xref ref-type="bibr" rid="B8">Battistone et al., 2020</xref>). However, its proposed expression in ICs suggests additional function on basic kidney function parameters such as urine volume, GFR and blood pH, which have not been studied so far.</p>
<p>Using a mouse model with enhanced green fluorescent protein (EGFP) under the control of the promoter of the V-ATPase B1 gene, Azroyan and coworkers (2015) found a colocalization of P2ry14 in type A-ICs of the collecting ducts (<xref ref-type="bibr" rid="B5">Azroyan et al., 2015</xref>). ICs occur in the collecting ducts of the cortex and outer medulla (<xref ref-type="bibr" rid="B54">Roy et al., 2015</xref>). However, the nature and origin of the IC populations in the cortex and medulla seem to be different. Whereas in mice type B-ICs are only present in the cortex region, type A-ICs can be detected in the cortex and outer medulla and are not present in papilla. Interestingly, type A-IC populations in cortex and medulla have a different developmental origin and can change their phenotype to type B-ICs and back depending on the diet (reviewed in <xref ref-type="bibr" rid="B2">Al-Awqati et al., 2011</xref>; <xref ref-type="bibr" rid="B30">Iervolino et al., 2020</xref>). The obvious discrepancy of the distribution of principal cells, ICs and the strong P2ry14 expression in the kidney papilla prompted us to screen for further cell types expressing P2ry14. In KO animals, &#xdf;-galactosidase activity was used for X-Gal or SPiDER-Gal staining of cells. In contrast to X-Gal, SPiDER-Gal is a non-diffusible fluorescent dye and marks enzyme-expressing cells more accurate according to the manufacturer. In the renal papilla, we found &#xdf;-galactosidase expression in Aqp2-expressing principal cells and in cells lining the tip of the papilla (<xref ref-type="fig" rid="F3">Figure 3C</xref>). <italic>In-situ</italic> hybridization in WT tissue using a P2ry14 probe and probes for pendrin (type B-ICs), Aqp2 (principal cells) and Gpr116 (type A-ICs) confirmed the expression of P2ry14 in type A-ICs of the outer medulla and principal cells of the papilla and cells lining the renal papilla (<xref ref-type="fig" rid="F4">Figure 4</xref>). Studies in rats showed that the epithelial cells covering the tip of the renal papilla differ from the urothelium lining the kidney&#x2019;s pelvis (<xref ref-type="bibr" rid="B62">Souza et al., 2018</xref>). To our best knowledge, no further characteristics of these epithelial cells are known. Several studies described the presence of adult kidney stem cells in the renal papilla of rats. Although not restricted to the terminal papilla, these stem cells seem to be enriched under the epithelial layer lining the renal papilla (<xref ref-type="bibr" rid="B3">Al-Awqati und Oliver, 2006</xref>; <xref ref-type="bibr" rid="B46">Oliver et al., 2009</xref>; <xref ref-type="bibr" rid="B47">Oliver et al., 2016</xref>). Whether P2ry14 is a characteristic feature of the mature epithelium lining the kidney papilla or if it is involved in the function of renal adult stem cells need to be investigated in future studies.</p>
<p>P2ry14 expression increases during postnatal kidney development (<xref ref-type="fig" rid="F2">Figure 2</xref>). This may suggest a role of P2ry14 in the organogenesis of the kidney. Therefore, we analyzed the renal morphology. Our results showed significant larger kidneys and cortices and smaller OSOM areas in KO compared to WT mice (<xref ref-type="sec" rid="s13">Supplementary Table S3</xref>). Although the absolute number of glomeruli was not different between WT and KO kidneys, the number of glomeruli in relation to the larger cortex or total kidney area was different. One can speculate that this reflects a compensatory hypertrophy of the cortex/kidney as shown in rats with unilateral nephrectomy (<xref ref-type="bibr" rid="B50">Pfaller et al., 1998</xref>). However, additional experiments are necessary to identify pathways regulated by P2ry14 that are involved in kidney development. Nevertheless, we clearly show that a constitutive loss of P2ry14 function has a developmental impact on renal morphology in mice (<xref ref-type="sec" rid="s13">Supplementary Table S3</xref>). Currently, there is no human monogenetic disease related to inactivating mutations in P2RY14. Furthermore, P2RY14 does not belong to those GPCRs showing a low tolerance of inactivation (<xref ref-type="bibr" rid="B58">Sch&#xf6;neberg und Liebscher, 2021</xref>; <xref ref-type="bibr" rid="B11">Cao et al., 2022</xref>). Although there are studies on expression quantitative trait loci (eQTL) suggesting a P2RY14 association with asthma (<xref ref-type="bibr" rid="B19">Ferreira et al., 2017</xref>), to our best knowledge renal phenotypes have not been associated with DNA variants in the human P2RY14 gene.</p>
<p>Our phenotype analysis showed that loss of P2ry14 resulted in lower urine volumes under chow and salt diet (<xref ref-type="fig" rid="F7">Figure 7</xref>) and a tendency to less water consumption under salt diet (see above). To differentiate between changes of glomerular filtration and downstream tubular mechanisms that regulate water homeostasis, we measured FITC-inulin clearance as a surrogate for glomerular filtration of WT and KO mice. Since the decline of FITC-inulin from blood was similar in both genotypes (<xref ref-type="sec" rid="s13">Supplementary Table S9</xref>) we assume that mechanisms downstream of the glomerulus are crucial for reduced water excretion due to loss of functional P2ry14. However, urine osmolality and components of the vasopressin-mediated water reabsorption pathway were not significantly different between the genotypes. Although lower urine volumes are in line with a reduced water intake in the KO one would expect a higher urine osmolality in KO considering comparable excretion of osmolytes in WT and KO due to dietary intake. Currently, we do not have a proper explanation for this discrepancy but we consider the determined urine osmolality with caution because the already low volume of mouse urine collected over 24&#xa0;h (1&#xa0;ml) probably underwent significant evaporation. Furthermore, since it is almost impossible to prevent food remains and feces falling into the collected urine, these contaminations may have added osmolytes equalizing osmolalities between WT and KO. Future studies with repetitive measurements of spontaneous urine will study the concentration abilities of KO and WT kidneys in more detail.</p>
<p>Type A-ICs are proton secreting cells and play a decisive role in acid base homeostasis (<xref ref-type="bibr" rid="B54">Roy et al., 2015</xref>). The expression of P2ry14 in type A-ICs promoted us to measure blood pH of WT and KO mice but no significant differences were detected indicating only a minor influence of P2ry14 on basic kidney functions. Currently, we interpret the significant lower urine volumes in KO animals rather as a result of a lower water intake than a direct cellular impact of P2ry14 function on collecting duct-mediated water reabsorption. Otherwise, we cannot exclude that global deletion of P2ry14 influences kidney function by changes of extra-renal factors. For example, histology of different tissues using the &#xdf;-galactosidase expression in KO animals shows positive staining in the adrenal cortex which could have implications in hormone secretion and eventually kidney regulation (own, unpublished data). Moreover, high P2ry14 expression in the gastrointestinal tract and lung may also influence water homeostasis. Further studies are needed to evaluate specific functions of P2ry14 in other tissues to generate a holistic picture of P2ry14 function in mammals.</p>
<p>Considering the high expression of P2ry14 in the renal papilla, we collected individual papillae of WT and KO animals under regular conditions and kidney-challenging conditions (high salt-diet) and analyzed the transcriptome depending on the presence of P2ry14. Analysis revealed 409 differentially expressed genes between chow diet-fed WT and KO mice and 628 differentially expressed genes in the group of salt-enriched diet-fed animals. An almost 10-fold higher number of differentially expressed genes was detected comparing the diets within one genotype (<xref ref-type="sec" rid="s13">Supplementary Figure S3A</xref>). Diet-dependent differences (salt-enriched semi-synthetic diet vs. chow diet) were more prominent than genotype-dependent differences, a finding which has been observed with other diets as well (<xref ref-type="bibr" rid="B35">Lede et al., 2017</xref>). Since the salt-enriched diet was a semi-synthetic diet, we found a great influence of the diet on gene expression. To identify genes and pathways strongly regulated by P2ry14 we filtered for genes differentially expressed under both diets and regulated concordantly. As a result only 19 genes including the GPCR Gpr171, Sptssb and the extracellular matrix proteins decorin, fibulin-1 and fibulin-7 were genotype-specifically regulated in renal papilla (<xref ref-type="sec" rid="s13">Supplementary Table S8</xref>).</p>
<p>Gpr171 was upregulated in P2ry14-deficient mice. P2ry14 and Gpr171 as well as other structurally related receptors (Gpr87, P2ry12, P2ry13) cluster cluster in close proximity at chromosome 3 (<xref ref-type="bibr" rid="B53">Rossi et al., 2013</xref>). The cause of upregulation of Gpr171 remains unclear. One can speculate that it could be due to either compensation for the functional loss of P2ry14 (assuming redundant functions) or an unknown combined expression regulation of both genes. GPR171 seems to be involved in different neuronal and immune functions (<xref ref-type="bibr" rid="B23">Gomes et al., 2013</xref>; <xref ref-type="bibr" rid="B9">Bobeck et al., 2017</xref>; <xref ref-type="bibr" rid="B21">Fujiwara et al., 2021</xref>) but its relevance in renal function has not been studied yet. In-depth analysis of the functional interaction and expression regulation of these receptors or studies with single and double-KO mouse models may help in uncovering GPR171 function in kidney.</p>
<p>We also found downregulation of Sptssb in KO mice linking P2ry14 to SM metabolism. Serine palmitoyltransferase (SPT) is the rate-limiting enzyme in the synthesis of SM (<xref ref-type="fig" rid="F5">Figure 5</xref>). It catalyzes the first step of the <italic>de novo</italic> synthesis of SM: the condensation reaction of an amino acid and fatty acyl-CoA, usually L-serine and palmitoyl-CoA resulting in 3-ketodihydrosphingosine. Downstream of SPT an abundance of enzymes modifies the generated long chain bases yielding a great variety of different SM species (<xref ref-type="bibr" rid="B26">Hannun and Obeid, 2011</xref>). In recent years, SM lost their image as molecules being only constituents of membranes. SM are involved in different cellular functions as signaling, lipid raft composition, influencing mitochondria, and enzymatic functions (<xref ref-type="bibr" rid="B27">Hannun and Obeid, 2008</xref>; <xref ref-type="bibr" rid="B28">Hannun and Obeid, 2018</xref>). Dysregulation of SM metabolism and changes in SM composition can be responsible for cardiovascular and metabolic diseases and cancer (<xref ref-type="bibr" rid="B14">Chatterjee, 1998</xref>; <xref ref-type="bibr" rid="B29">Holland und Summers, 2008</xref>; <xref ref-type="bibr" rid="B33">Kroll et al., 2020</xref>). Disturbances in SM metabolism in the kidney were found to play a critical role in chronic kidney diseases (<xref ref-type="bibr" rid="B44">Merscher und Fornoni, 2014</xref>; <xref ref-type="bibr" rid="B1">Abou et al., 2017</xref>; <xref ref-type="bibr" rid="B71">Zhang et al., 2019</xref>). Decreased expression of one of the regulating subunits of SPT (SPTssb; <xref ref-type="sec" rid="s13">Supplementary Table S8</xref>) pointed to possible changes in SM metabolism. Because the active enzyme is a trimer of two large subunits (SPTLC1 and 2 or SPTLC1 and 3) and one regulating subunit (SPTssa or SPTssb) we investigated the regional distribution of the subunits in the kidney using qPCR on samples from renal cortex, medulla and papilla. SPTLC 1 and 2 are the dominant large subunits expressed in the mouse kidney. The regulating subunits were both abundantly expressed in the papilla region (see above). However, Sptssb shows a marked increase in expression from cortex towards the papilla. This suggests that Sptssb plays a distinct role in the renal papilla whereas Sptssa functions as a housekeeping subunit. As stated above, small subunits of SPT render the enzyme fully active. Furthermore, the small subunit included in the enzyme is crucial for substrate specificity (<xref ref-type="bibr" rid="B25">Han et al., 2009</xref>). SPT in microsomes prepared from yeast expressing different isoenzymes of SPT showed substrate specificity depending on the small subunit. SPT comprising small subunit a prefers C14 or C16 acyl-CoA whereas small subunit b containing SPT prefers C18. Microsomes of CHO LyB cells expressing SPTLC1/2 only showed substantial activity with C18-CoA as a substrate when transfected with SPTssa but not with SPTssb (<xref ref-type="bibr" rid="B25">Han et al., 2009</xref>). A certain SPTssb mutation, <italic>Stellar (Stl)</italic>, results in an increased affinity of SPT toward C18 fatty acyl-CoA resulting in accumulation of C20 long chain bases (LCBs) and neurodegeneration (<xref ref-type="bibr" rid="B72">Zhao et al., 2015</xref>). Therefore, we set out to investigate possible changes in SM species of P2ry14-deficient compared with WT papillae. We analyzed different SM species using HPTLC and ESI-IT MS. Knockout of P2ry14 resulted in a shift towards higher chain lengths (<xref ref-type="fig" rid="F6">Figure 6</xref>). This is in line with previous results highlighting out the crucial role of small subunits of SPT with respect to substrate specificity (<xref ref-type="bibr" rid="B25">Han et al., 2009</xref>; <xref ref-type="bibr" rid="B72">Zhao et al., 2015</xref>). The overall content of SM in the papilla was unchanged between WT and KO mice (<xref ref-type="sec" rid="s13">Supplementary Figure S4</xref>). In addition, we found more genes associated with SM metabolism and signaling differentially expressed between WT and KO with possible implications for signaling (S1pr3), sphingosine and sphingosine-1-phosphate (S1P) generation (aCer2) and glucocerebroside metabolism (Ugcg) (<xref ref-type="fig" rid="F5">Figure 5A</xref>). Challenging the kidney with a salt-enriched diet changed the regulation of enzymes involved in SM metabolism (except for Sptssb) towards increased expression of two phosphatases involved in breakdown of the signaling molecules S1P and C1P (S1pp2, Cptp) and downregulation of the lysosomal sphingomyelinase (<xref ref-type="fig" rid="F5">Figure 5B</xref>). The confirmation of changes in SM composition due to downregulation of Sptssb in P2ry14-deficient mice by mass spectrometry suggests a metabolic role of P2ry14 in kidney papillae. The specific pathways linking P2ry14 and SM metabolism may involve the G<sub>i</sub> protein/adenylyl cyclase pathway. Thus, we propose P2ry14 to be a novel regulator of SM composition in the renal papilla.</p>
<p>In the light of a changed microscopic kidney structure, the differential expression of the extracellular matrix components fibulin-1, fibulin-7 and decorin was of particular interest. Upregulation of decorin and downregulation of fibulin-1 and -7 may be indicative for changes in extracellular matrix composition and interactions in the renal papilla. Little is known about the function of fibulin-1 and -7 in the kidney. Expression of fibulin-1 is decreased in renal cell carcinoma and suppresses progression of cancer (<xref ref-type="bibr" rid="B67">Xiao et al., 2013</xref>). Fibulin-7 is involved in processes of calcification (<xref ref-type="bibr" rid="B65">Tsunezumi et al., 2018</xref>). The renal function of decorin has been studied more thoroughly. Decorin seems to be increased in processes of kidney fibrosis and development of chronic kidney disease (<xref ref-type="bibr" rid="B66">Vleming et al., 1995</xref>; <xref ref-type="bibr" rid="B63">Stokes et al., 2000</xref>). However, its effect appears to be rather beneficial in terms of preventing apoptosis, inflammation and fibrosis (<xref ref-type="bibr" rid="B56">Schaefer et al., 2007</xref>). Presumably, the interaction of decorin and TGF-&#x3b2; is of great significance. Decorin inhibits TGF-&#x3b2;-signaling (<xref ref-type="bibr" rid="B69">Yamaguchi et al., 1990</xref>) thereby preventing accumulation of extracellular matrix and fibrosis (<xref ref-type="bibr" rid="B10">Border et al., 1992</xref>). The injection of decorin hampered the TGF-&#x3b2;-mediated accumulation of extracellular matrix components in a rat model of glomerulonephritis (<xref ref-type="bibr" rid="B10">Border et al., 1992</xref>). Similar results were observed by overexpressing decorin in rat skeletal muscle <italic>in vivo</italic> (<xref ref-type="bibr" rid="B31">Isaka et al., 1996</xref>). Furthermore, decorin seems to be involved in regenerative processes in the kidney (<xref ref-type="bibr" rid="B55">Sallustio et al., 2017</xref>). Decorin binds and neutralizes TGF-&#x3b2; which is thought to be a central pathway in tissue fibrosis (<xref ref-type="bibr" rid="B31">Isaka et al., 1996</xref>). Hypothetically, upregulation of decorin in P2ry14-deficient mice might mediate antifibrotic and nephroprotective effects by inhibiting the TGF-&#x3b2;-pathway. In the light of the protective effect of P2ry14 inhibition in a mouse model of acute kidney injury (<xref ref-type="bibr" rid="B8">Battistone et al., 2020</xref>) this might be a promising field of future research.</p>
</sec>
<sec sec-type="conclusion" id="s6">
<title>Conclusion</title>
<p>We found P2ry14 to be strongly expressed in collecting duct principal cells of the renal papilla. Increasing P2ry14 expression during postnatal development and a changed renal morphology point to a role in organogenesis. Basic kidney functions such as urine volume production as well as SM metabolism are influenced by P2ry14. Eventually, our work encourage future research to further illuminate the function of P2ry14 in the kidney including its expression in a not yet exactly characterized epithelial cell type of the renal papilla and the possible involvement of P2ry14 in nephroprotection by regulation of decorin.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s7">
<title>Data availability statement</title>
<p>The data presented in the study are deposited in the NCBI repository in BioProject (ID: PRJNA923283) under the following link: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA923283">https://www.ncbi.nlm.nih.gov/bioproject/PRJNA923283</ext-link>.</p>
</sec>
<sec id="s8">
<title>Ethics statement</title>
<p>The animal study was reviewed and approved by the respective regional government agency of the State of Saxony, Germany (T46/12, T07/13, T21/18, and TVV20/20).</p>
</sec>
<sec id="s9">
<title>Author contributions</title>
<p>FB, AS, and AB performed the main body of experiments. FB and VL analysed the RNA-seq data. JB and AR were responsible for histology and in-situ techniques and KW analysed the kidney sections. YP, KE, and JS performed and evaluated the sphingolipid experiments. TS and AS were supervising the project and FB, AS, and TS wrote the manuscript with contributions of all authors. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s10">
<title>Funding</title>
<p>The authors&#x2019; research was mainly supported by the German Research Foundation (DFG) in CRC1423 project number 421152132 and in CRC1052 project Z3. Furthermore, we kindly acknowledge Monika Putscher for her financial support of our scientific work. The authors acknowledge the financial support by the Open Access Publishing Fund of Leipzig University supported by the German Research Foundation within the program Open Access Publication Funding.</p>
</sec>
<ack>
<p>We are grateful to Akhil Velluva for the help with data management of the RNASeq data.</p>
</ack>
<sec sec-type="COI-statement" id="s11">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s12">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s13">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcell.2023.1128456/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcell.2023.1128456/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.zip" id="SM1" mimetype="application/zip" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>El Jalkh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tatiana Eid</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Fornoni</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Marples</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zeidan</surname>
<given-names>Y. H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Translational aspects of sphingolipid metabolism in renal disorders</article-title>. <source>Int. J. Mol. Sci.</source> <volume>18</volume> (<issue>12</issue>), <fpage>2528</fpage>. <pub-id pub-id-type="doi">10.3390/ijms18122528</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Awqati</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Qais</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Xaio</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Differentiation of intercalated cells in the kidney</article-title>. <source>Physiol. (Bethesda, Md</source> <volume>26</volume> (<issue>4</issue>), <fpage>266</fpage>&#x2013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1152/physiol.00008.2011</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Awqati</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Oliver</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>The kidney papilla is a stem cells niche</article-title>. <source>Stem Cell. Rev.</source> <volume>2</volume> (<issue>3</issue>), <fpage>181</fpage>&#x2013;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1007/s12015-006-0046-3</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arase</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Uchida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kajitani</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ono</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tamaki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Oda</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>The UDP-glucose receptor P2RY14 triggers innate mucosal immunity in the female reproductive tract by inducing IL-8</article-title>. <source>J. Immunol.</source> <volume>182</volume> (<issue>11</issue>), <fpage>7074</fpage>&#x2013;<lpage>7084</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0900001</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Argraves</surname>
<given-names>W. S.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Burgess</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Dickerson</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure</article-title>. <source>J. Cell. Biol.</source> <volume>111</volume> (<issue>6</issue>), <fpage>3155</fpage>&#x2013;<lpage>3164</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.111.6.3155</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azroyan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cortez-Retamozo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bouley</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liberman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Kiselev</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Renal intercalated cells sense and mediate inflammation via the P2Y14 receptor</article-title>. <source>PloS one</source> <volume>10</volume> (<issue>3</issue>), <fpage>e0121419</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0121419</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barrett</surname>
<given-names>M. O.</given-names>
</name>
<name>
<surname>Sesma</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>C. B.</given-names>
</name>
<name>
<surname>Jayasekara</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Lazarowski</surname>
<given-names>E. R.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils</article-title>. <source>Mol. Pharmacol.</source> <volume>84</volume> (<issue>1</issue>), <fpage>41</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1124/mol.113.085654</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bassil</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Bourdu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Townson</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Wheeldon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jarvie</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Zebda</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>UDP-glucose modulates gastric function through P2Y14 receptor-dependent and -independent mechanisms</article-title>. <source>Am. J. Physiol. Gastrointest. Liver Physiol.</source> <volume>296</volume> (<issue>4</issue>), <fpage>G923</fpage>&#x2013;<lpage>G930</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.90363.2008</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Battistone</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Mendelsohn</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Spallanzani</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Allegretti</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Liberman</surname>
<given-names>R. N.</given-names>
</name>
<name>
<surname>Sesma</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Proinflammatory P2Y14 receptor inhibition protects against ischemic acute kidney injury in mice</article-title>. <source>J. Clin. Investigation</source> <volume>130</volume> (<issue>7</issue>), <fpage>3734</fpage>&#x2013;<lpage>3749</lpage>. <pub-id pub-id-type="doi">10.1172/jci134791</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bobeck</surname>
<given-names>E. N.</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pena</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Clem</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Mezei</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>The BigLEN-gpr171 peptide receptor system within the basolateral amygdala regulates anxiety-like behavior and contextual fear conditioning</article-title>. <source>Neuropsychopharmacol. official Publ. Am. Coll. Neuropsychopharmacol.</source> <volume>42</volume> (<issue>13</issue>), <fpage>2527</fpage>&#x2013;<lpage>2536</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2017.79</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Border</surname>
<given-names>W. A.</given-names>
</name>
<name>
<surname>Noble</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Harper</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pierschbacher</surname>
<given-names>M. D.</given-names>
</name>
<etal/>
</person-group> (<year>1992</year>). <article-title>Natural inhibitor of transforming growth factor-&#x3b2; protects against scarring in experimental kidney disease</article-title>. <source>Nature</source> <volume>360</volume> (<issue>6402</issue>), <fpage>361</fpage>&#x2013;<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1038/360361a0</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Identifying key genes and functionally enriched pathways in Th2-high asthma by weighted gene co-expression network analysis</article-title>. <source>BMC Med. genomics</source> <volume>15</volume> (<issue>1</issue>), <fpage>110</fpage>. <pub-id pub-id-type="doi">10.1186/s12920-022-01241-9</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carter</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Fricks</surname>
<given-names>I. P.</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>M. O.</given-names>
</name>
<name>
<surname>Burianek</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor</article-title>. <source>Mol. Pharmacol.</source> <volume>76</volume> (<issue>6</issue>), <fpage>1341</fpage>&#x2013;<lpage>1348</lpage>. <pub-id pub-id-type="doi">10.1124/mol.109.058578</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Macdonald</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Sarau</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Ames</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Foley</surname>
<given-names>J. J.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>A G protein-coupled receptor for UDP-glucose</article-title>. <source>J. Biol. Chem.</source> <volume>275</volume> (<issue>15</issue>), <fpage>10767</fpage>&#x2013;<lpage>10771</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.275.15.10767</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chatterjee</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Sphingolipids in atherosclerosis and vascular biology</article-title>. <source>Arteriosclerosis, thrombosis, Vasc. Biol.</source> <volume>18</volume> (<issue>10</issue>), <fpage>1523</fpage>&#x2013;<lpage>1533</lpage>. <pub-id pub-id-type="doi">10.1161/01.atv.18.10.1523</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Nair</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Battistone</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>P&#x103;unescu</surname>
<given-names>T. G.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Transcriptomes of major renal collecting duct cell types in mouse identified by single-cell RNA-seq</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>114</volume> (<issue>46</issue>), <fpage>E9989</fpage>&#x2013;<lpage>E9998</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1710964114</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yusuf</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kook</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Attar</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Purinergic P2Y receptor modulates stress-induced hematopoietic stem/progenitor cell senescence</article-title>. <source>J. Clin. Investigation</source> <volume>124</volume> (<issue>7</issue>), <fpage>3159</fpage>&#x2013;<lpage>3171</lpage>. <pub-id pub-id-type="doi">10.1172/jci61636</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clark</surname>
<given-names>J. Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Knepper</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Representation and relative abundance of cell-type selective markers in whole-kidney RNA-Seq data</article-title>. <source>Kidney Int.</source> <volume>95</volume> (<issue>4</issue>), <fpage>787</fpage>&#x2013;<lpage>796</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2018.11.028</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engel</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Schiller</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>M&#xfc;ller</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dannenberger</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jakop</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The phospholipid composition of kangaroo spermatozoa verified by mass spectrometric lipid analysis</article-title>. <source>Lipids</source> <volume>52</volume> (<issue>10</issue>), <fpage>857</fpage>&#x2013;<lpage>869</lpage>. <pub-id pub-id-type="doi">10.1007/s11745-017-4283-9</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>M. A. R.</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Penninx</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bain</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Vicente</surname>
<given-names>C. T.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Gene-based analysis of regulatory variants identifies 4 putative novel asthma risk genes related to nucleotide synthesis and signaling</article-title>. <source>J. allergy Clin. Immunol.</source> <volume>139</volume> (<issue>4</issue>), <fpage>1148</fpage>&#x2013;<lpage>1157</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2016.07.017</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freeman</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tsui</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Emson</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>Vawter</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Naheed</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>Cloning, pharmacology, and tissue distribution of G-protein-coupled receptor GPR105 (KIAA0001) rodent orthologs</article-title>. <source>Genomics</source> <volume>78</volume> (<issue>3</issue>), <fpage>124</fpage>&#x2013;<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1006/geno.2001.6662</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujiwara</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Torphy</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>E. N.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Borcherding</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The GPR171 pathway suppresses T cell activation and limits antitumor immunity</article-title>. <source>Nat. Commun.</source> <volume>12</volume> (<issue>1</issue>), <fpage>5857</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-021-26135-9</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gendaszewska-Darmach</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>W&#x119;g&#x142;owska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Walczak-Drzewiecka</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kara&#x15b;</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Nucleoside 5&#x2032;-O-monophosphorothioates as modulators of the P2Y14 receptor and mast cell degranulation</article-title>. <source>Oncotarget</source> <volume>7</volume> (<issue>43</issue>), <fpage>69358</fpage>&#x2013;<lpage>69370</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.12541</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomes</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Aryal</surname>
<given-names>D. K.</given-names>
</name>
<name>
<surname>Wardman</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gagnidze</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rodriguiz</surname>
<given-names>R. M.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>110</volume> (<issue>40</issue>), <fpage>16211</fpage>&#x2013;<lpage>16216</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1312938110</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haanes</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Agmund</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Edvinsson</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Characterization of the contractile P2Y14 receptor in mouse coronary and cerebral arteries</article-title>. <source>FEBS Lett.</source> <volume>588</volume> (<issue>17</issue>), <fpage>2936</fpage>&#x2013;<lpage>2943</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2014.05.044</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Gable</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Niranjanakumari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Moitra</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>106</volume> (<issue>20</issue>), <fpage>8186</fpage>&#x2013;<lpage>8191</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0811269106</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hannun</surname>
<given-names>Y. A.</given-names>
</name>
<name>
<surname>Obeid</surname>
<given-names>L. M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Many ceramides</article-title>. <source>J. Biol. Chem.</source> <volume>286</volume> (<issue>32</issue>), <fpage>27855</fpage>&#x2013;<lpage>27862</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.r111.254359</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hannun</surname>
<given-names>Y. A.</given-names>
</name>
<name>
<surname>Obeid</surname>
<given-names>L. M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Principles of bioactive lipid signalling: Lessons from sphingolipids</article-title>. <source>Nat. Rev. Mol. Cell. Biol.</source> <volume>9</volume> (<issue>2</issue>), <fpage>139</fpage>&#x2013;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2329</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hannun</surname>
<given-names>Y. A.</given-names>
</name>
<name>
<surname>Obeid</surname>
<given-names>L. M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Sphingolipids and their metabolism in physiology and disease</article-title>. <source>Nat. Rev. Mol. Cell. Biol.</source> <volume>19</volume> (<issue>3</issue>), <fpage>175</fpage>&#x2013;<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1038/nrm.2017.107</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hildebrand</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Romar&#x00ED;s</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Heineg&#x00E5;rd</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Twardzik</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Border</surname>
<given-names>W. A.</given-names>
</name>
<etal/>
</person-group> (<year>1994</year>). <article-title>Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta</article-title>. <source>Biochem. J.</source> <volume>302</volume> (<issue>Pt 2)(Pt 2</issue>), <fpage>527</fpage>&#x2013;<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1042/bj3020527</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holland</surname>
<given-names>W. L.</given-names>
</name>
<name>
<surname>Summers</surname>
<given-names>S. A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Sphingolipids, insulin resistance, and metabolic disease: New insights from <italic>in vivo</italic> manipulation of sphingolipid metabolism</article-title>. <source>Endocr. Rev.</source> <volume>29</volume> (<issue>4</issue>), <fpage>381</fpage>&#x2013;<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1210/er.2007-0025</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iervolino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Prosperi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>La Motte Luigi</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Petrillo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Spagnuolo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>D&#x27;Acierno</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Potassium depletion induces cellular conversion in the outer medullary collecting duct altering Notch signaling pathway</article-title>. <source>Sci. Rep.</source> <volume>10</volume> (<issue>1</issue>), <fpage>5708</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-61882-7</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Isaka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Brees</surname>
<given-names>D. K.</given-names>
</name>
<name>
<surname>Ikegaya</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kaneda</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Imai</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Noble</surname>
<given-names>N. A.</given-names>
</name>
<etal/>
</person-group> (<year>1996</year>). <article-title>Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney</article-title>. <source>Nat. Med.</source> <volume>2</volume> (<issue>4</issue>), <fpage>418</fpage>&#x2013;<lpage>423</lpage>. <pub-id pub-id-type="doi">10.1038/nm0496-418</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karcz</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Whitehead</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Nakano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nakano</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Grimm</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>J. G.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>UDP-glucose and P2Y14 receptor amplify allergen-induced airway eosinophilia</article-title>. <source>J. Clin. Investigation</source> <volume>131</volume> (<issue>7</issue>), <fpage>e140709</fpage>. <pub-id pub-id-type="doi">10.1172/jci140709</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kroll</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>H. E.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>M. H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Antineoplastic agents targeting sphingolipid pathways</article-title>. <source>Front. Oncol.</source> <volume>10</volume>, <fpage>833</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2020.00833</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lazarowski</surname>
<given-names>E. R.</given-names>
</name>
<name>
<surname>Harden</surname>
<given-names>T. K.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>UDP-sugars as extracellular signaling molecules: Cellular and physiologic consequences of P2Y14 receptor activation</article-title>. <source>Mol. Pharmacol.</source> <volume>88</volume> (<issue>1</issue>), <fpage>151</fpage>&#x2013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1124/mol.115.098756</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lede</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Meusel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Garten</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Popkova</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Penke</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor</article-title>. <source>PloS one</source> <volume>12</volume> (<issue>2</issue>), <fpage>e0172000</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0172000</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gregor</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Adams Eyal</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Attar Miura</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. B.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bone-marrowhematopoietic stem cells</article-title>. <source>Genes. &#x26; Dev.</source> <volume>17</volume> (<issue>13</issue>), <fpage>1592</fpage>&#x2013;<lpage>1604</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1071503</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Knepper</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Deep sequencing in microdissected renal tubules identifies nephron segment-specific transcriptomes</article-title>. <source>J. Am. Soc. Nephrol. JASN</source> <volume>26</volume> (<issue>11</issue>), <fpage>2669</fpage>&#x2013;<lpage>2677</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2014111067</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. Y.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Selective induction of P2Y14 receptor by RANKL promotes osteoclast formation</article-title>. <source>Mol. Cells</source> <volume>36</volume> (<issue>3</issue>), <fpage>273</fpage>&#x2013;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1007/s10059-013-0226-3</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>P2RY14 is a potential biomarker of tumor microenvironment immunomodulation and favorable prognosis in patients with head and neck cancer</article-title>. <source>Front. Genet.</source> <volume>12</volume>, <fpage>670746</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2021.670746</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Love</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Anders</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol.</source> <volume>15</volume> (<issue>12</issue>), <fpage>550</fpage>. <pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMahon</surname>
<given-names>A. P.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Development of the mammalian kidney</article-title>. <source>Curr. Top. Dev. Biol.</source> <volume>117</volume>, <fpage>31</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/bs.ctdb.2015.10.010</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meister</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ricken</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Burkhardt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Thiery</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pfannkuche</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The G protein-coupled receptor P2Y14 influences insulin release and smooth muscle function in mice</article-title>. <source>J. Biol. Chem.</source> <volume>289</volume> (<issue>34</issue>), <fpage>23353</fpage>&#x2013;<lpage>23366</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m114.580803</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merkwitz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Blaschuk</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Schulz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ricken</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Comments on methods to suppress endogenous &#x3b2;-galactosidase activity in mouse tissues expressing the LacZ reporter gene</article-title>. <source>J. Histochem. Cytochem. official J. Histochem. Soc.</source> <volume>64</volume> (<issue>10</issue>), <fpage>579</fpage>&#x2013;<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1369/0022155416665337</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merscher</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fornoni</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Podocyte pathology and nephropathy - sphingolipids in glomerular diseases</article-title>. <source>Front. Endocrinol.</source> <volume>5</volume>, <fpage>127</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2014.00127</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mikolajewicz</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Komarova</surname>
<given-names>S. V.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Role of UDP-sugar receptor P2Y14 in murine osteoblasts</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume> (<issue>8</issue>), <fpage>2747</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21082747</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliver</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Klinakis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cheema</surname>
<given-names>F. H.</given-names>
</name>
<name>
<surname>Friedlander</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sampogna</surname>
<given-names>R. V.</given-names>
</name>
<name>
<surname>Martens</surname>
<given-names>T. P.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Proliferation and migration of label-retaining cells of the kidney papilla</article-title>. <source>J. Am. Soc. Nephrol. JASN</source> <volume>20</volume> (<issue>11</issue>), <fpage>2315</fpage>&#x2013;<lpage>2327</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2008111203</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliver</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Sampogna</surname>
<given-names>R. V.</given-names>
</name>
<name>
<surname>Jalal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q. Y.</given-names>
</name>
<name>
<surname>Dahan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>A subpopulation of label-retaining cells of the kidney papilla regenerates injured kidney medullary tubules</article-title>. <source>Stem Cell. Rep.</source> <volume>6</volume> (<issue>5</issue>), <fpage>757</fpage>&#x2013;<lpage>771</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2016.03.008</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patritti-Cram</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Coover</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Jankowski</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Ratner</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Purinergic signaling in peripheral nervous system glial cells</article-title>. <source>Glia</source> <volume>69</volume> (<issue>8</issue>), <fpage>1837</fpage>&#x2013;<lpage>1851</lpage>. <pub-id pub-id-type="doi">10.1002/glia.23969</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pellegrino</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Di Veroli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Valeri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Goracci</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cruciani</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>LC/MS lipid profiling from human serum: A new method for global lipid extraction</article-title>. <source>Anal. Bioanal. Chem.</source> <volume>406</volume> (<issue>30</issue>), <fpage>7937</fpage>&#x2013;<lpage>7948</lpage>. <pub-id pub-id-type="doi">10.1007/s00216-014-8255-0</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfaller</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Seppi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ohno</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Giebisch</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>F. X.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Quantitative morphology of renal cortical structures during compensatory hypertrophy</article-title>. <source>Exp. Nephrol.</source> <volume>6</volume> (<issue>4</issue>), <fpage>308</fpage>&#x2013;<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1159/000020538</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Breyer</surname>
<given-names>M. D.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Measurement of glomerular filtration rate in conscious mice</article-title>. <source>Methods Mol. Biol. Clift. N.J.)</source> <volume>466</volume>, <fpage>61</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-59745-352-3_5</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Whitt</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>R. C.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance</article-title>. <source>Am. J. physiology. Ren. physiology</source> <volume>286</volume> (<issue>3</issue>), <fpage>F590</fpage>&#x2013;<lpage>F596</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00324.2003</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lemoli</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Goodell</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Gpr171, a putative P2Y-like receptor, negatively regulates myeloid differentiation in murine hematopoietic progenitors</article-title>. <source>Exp. Hematol.</source> <volume>41</volume> (<issue>1</issue>), <fpage>102</fpage>&#x2013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.exphem.2012.09.007</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mohammad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pastor-Soler N&#xfa;ria</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Collecting duct intercalated cell function and regulation</article-title>. <source>Clin. J. Am. Soc. Nephrol. CJASN</source> <volume>10</volume> (<issue>2</issue>), <fpage>305</fpage>&#x2013;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.2215/CJN.08880914</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sallustio</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Curci</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Aloisi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Toma</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Marulli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Serino</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Inhibin-A and decorin secreted by human adult renal stem/progenitor cells through the TLR2 engagement induce renal tubular cell regeneration</article-title>. <source>Sci. Rep.</source> <volume>7</volume> (<issue>1</issue>), <fpage>8225</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-08474-0</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaefer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tsalastra</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Babelova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Baliova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Minnerup</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sorokin</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and mammalian target of rapamycin</article-title>. <source>Am. J. Pathology</source> <volume>170</volume> (<issue>1</issue>), <fpage>301</fpage>&#x2013;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2007.060497</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sch&#xf6;neberg</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hermsdorf</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Engemaier</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Engel</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liebscher</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Thor</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Structural and functional evolution of the P2Y12-like receptor group</article-title>. <source>Purinergic Signal.</source> <volume>3</volume> (<issue>4</issue>), <fpage>255</fpage>&#x2013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1007/s11302-007-9064-0</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sch&#xf6;neberg</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liebscher</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Mutations in G Protein-Coupled receptors: Mechanisms, pathophysiology and potential therapeutic approaches</article-title>. <source>Pharmacol. Rev.</source> <volume>73</volume> (<issue>1</issue>), <fpage>89</fpage>&#x2013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1124/pharmrev.120.000011</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scrivens</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dickenson</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Functional expression of the P2Y14 receptor in murine T-lymphocytes</article-title>. <source>Br. J. Pharmacol.</source> <volume>146</volume> (<issue>3</issue>), <fpage>435</fpage>&#x2013;<lpage>444</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0706322</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shah</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Moharram</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Kazi</surname>
<given-names>J. U.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Acute leukemia cells resistant to PI3K/mTOR inhibition display upregulation of P2RY14 expression</article-title>. <source>Clin. epigenetics</source> <volume>10</volume>, <fpage>83</fpage>. <pub-id pub-id-type="doi">10.1186/s13148-018-0516-x</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skelton</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Platt</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Human immature monocyte-derived dendritic cells express the G protein-coupled receptor GPR105 (KIAA0001, P2Y14) and increase intracellular calcium in response to its agonist, uridine diphosphoglucose</article-title>. <source>J. Immunol.</source> <volume>171</volume> (<issue>4</issue>), <fpage>1941</fpage>&#x2013;<lpage>1949</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.171.4.1941</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Souza</surname>
<given-names>N. P.</given-names>
</name>
<name>
<surname>Hard</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>K. W.</given-names>
</name>
<name>
<surname>Pennington</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Epithelium lining rat renal papilla: Nomenclature and association with chronic progressive nephropathy (CPN)</article-title>. <source>Toxicol. Pathol.</source> <volume>46</volume> (<issue>3</issue>), <fpage>266</fpage>&#x2013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1177/0192623318762694</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stokes</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Holler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hudkins</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Eitner</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fogo</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease</article-title>. <source>Kidney Int.</source> <volume>57</volume> (<issue>2</issue>), <fpage>487</fpage>&#x2013;<lpage>498</lpage>. <pub-id pub-id-type="doi">10.1046/j.1523-1755.2000.00868.x</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swanson</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Jeng</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Erspamer</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>McWeeney</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Salt-sensitive transcriptome of isolated kidney distal tubule cells</article-title>. <source>Physiol. genomics</source> <volume>51</volume> (<issue>4</issue>), <fpage>125</fpage>&#x2013;<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1152/physiolgenomics.00119.2018</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsunezumi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sugiura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Oinam</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Thang</surname>
<given-names>B. Q.</given-names>
</name>
<name>
<surname>Sada</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Fibulin-7, a heparin binding matricellular protein, promotes renal tubular calcification in mice</article-title>. <source>Matrix Biol.</source> <volume>74</volume>, <fpage>5</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2018.04.014</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vleming</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Baelde</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Westendorp</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Daha</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>van Es</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Bruijn</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix</article-title>. <source>Clin. Nephrol.</source> <volume>44</volume> (<issue>4</issue>), <fpage>211</fpage>&#x2013;<lpage>219</lpage>. <comment>Avaliable At: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/8575119">https://www.ncbi.nlm.nih.gov/pubmed/8575119</ext-link>
</comment>.</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Fibulin-1 is down-regulated through promoter hypermethylation and suppresses renal cell carcinoma progression</article-title>. <source>J. Urol.</source> <volume>190</volume> (<issue>1</issue>), <fpage>291</fpage>&#x2013;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1016/j.juro.2013.01.098</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Morinaga</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Talukdar</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity</article-title>. <source>J. Immunol.</source> <volume>189</volume> (<issue>4</issue>), <fpage>1992</fpage>&#x2013;<lpage>1999</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1103207</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamaguchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Ruoslahti</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Negative regulation of transforming growth factor-beta by the proteoglycan decorin</article-title>. <source>Nature</source> <volume>346</volume> (<issue>6281</issue>), <fpage>281</fpage>&#x2013;<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1038/346281a0</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaidman</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Tomilin</surname>
<given-names>V. N.</given-names>
</name>
<name>
<surname>Hassanzadeh Khayyat</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Damarla</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tidmore</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Capen</surname>
<given-names>D. E.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Adhesion-GPCR Gpr116 (ADGRF5) expression inhibits renal acid secretion</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>117</volume> (<issue>42</issue>), <fpage>26470</fpage>&#x2013;<lpage>26481</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2007620117</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Macula densa SGLT1-NOS1-tubuloglomerular feedback pathway, a new mechanism for glomerular hyperfiltration during hyperglycemia</article-title>. <source>J. Am. Soc. Nephrol. JASN</source> <volume>30</volume> (<issue>4</issue>), <fpage>578</fpage>&#x2013;<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2018080844</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Spassieva</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gable</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L. Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Elevation of 20-carbon long chain bases due to a mutation in serine palmitoyltransferase small subunit b results in neurodegeneration</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>112</volume> (<issue>42</issue>), <fpage>12962</fpage>&#x2013;<lpage>12967</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1516733112</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>